ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,21
-0,82%
Dow Jones
40 211,72
0,00%
DAX
18 483,20
-0,63%
Brent Oil
82,985
-1,61%
Bitcoin
63 735,14
-1,72%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
27/06/201614h00PR Newswire (US)Analysts View on Drug Manufacturers - Other Equities - Endo Intl., Teva Pharma, Synergy Pharma, and Orexigen TherapeuticsNYSE:TEVATeva Pharmaceutical Industries Ltd
24/06/201614h46Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
24/06/201613h11Business WireTeva Receives CHMP Positive Opinion for CINQAERO® (reslizumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
23/06/201614h30Business WireTeva Settles Patent Litigation with AstraZeneca Allowing Teva to Commercialize Its Generic Version of Byetta® (Exenatide Inj...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/06/201615h30Dow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNYSE:TEVATeva Pharmaceutical Industries Ltd
20/06/201614h00Business WireTeva to Present Data Highlighting SD-809 at 20th International Congress of Parkinson’s Disease and Movement DisordersNYSE:TEVATeva Pharmaceutical Industries Ltd
16/06/201617h07Dow Jones NewsTeva, Looking to Close Actavis Deal, Sells $40 Million Portfolio to SagentNYSE:TEVATeva Pharmaceutical Industries Ltd
15/06/201602h11Dow Jones NewsLilly: German Supreme Court Grants Appeal in Dispute With ActavisNYSE:TEVATeva Pharmaceutical Industries Ltd
13/06/201614h00Business WireTeva Announces Voluntary Suspension of Marketing for ZECUITY® in the U.S.NYSE:TEVATeva Pharmaceutical Industries Ltd
11/06/201619h58Dow Jones NewsDr. Reddy's Buying Eight Drugs From Teva for U.S. MarketNYSE:TEVATeva Pharmaceutical Industries Ltd
10/06/201620h20Business WireTeva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
07/06/201621h33Business WireTeva Gains Recommendation for Approval from FDA Advisory Committees for VANTRELA™ ER (hydrocodone bitartrate) Extended-Rele...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/06/201614h00Business WireTeva to Present at the Jefferies 2016 Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
06/06/201614h00Business WireTeva to Present at the Goldman Sachs 37th Annual Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201622h11Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201618h29Dow Jones NewsFDA Rejects Teva's Application for Huntington's Drug -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201615h10Dow Jones NewsFDA Rejects Teva's Application For Huntington's DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201615h07Dow Jones NewsFDA Rejects Teva's Application for Huntington's Drug -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201614h54Dow Jones NewsFDA Asks Teva for More Information on Huntington's Drug -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201614h39Dow Jones NewsFDA Asks Teva for More Information on Huntington's DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201614h00Business WireTeva to Present at the Bernstein 32nd Annual Strategic Decisions ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201613h00Business WireTeva Receives Complete Response Letter for NDA for SD-809 for the Treatment of Chorea Associated with Huntington DiseaseNYSE:TEVATeva Pharmaceutical Industries Ltd
30/05/201619h00PR Newswire (US)Teva Achieves Positive Conclusion for the European Decentralised Procedure (DCP) for BRALTUS® (tiotropium bromide)NYSE:TEVATeva Pharmaceutical Industries Ltd
18/05/201614h30PR Newswire (US)Emerald Medical Applications Corp (OTCQB: MRLA) Appoints Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to its Scientific...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/201614h40Dow Jones NewsAstraZeneca Asthma Drug Shows Positive ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
12/05/201614h00Business WireTeva to Present New Data at the 2016 American Thoracic Society (ATS) International ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
10/05/201614h10Dow Jones NewsAllergan Realigns Executive Team, Outlines $10 Billion Stock BuybackNYSE:TEVATeva Pharmaceutical Industries Ltd
10/05/201612h45GlobeNewswire Inc.Adamis Pharmaceuticals Announces License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled SyringeNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201617h00Business WireTeva to Present at the Bank of America Merrill Lynch 2016 Health Care ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201615h49Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

BIT
SEML
Exchange Traded
AQSE
EMAD.GB
Spdr Msci Em Asia Ucits ...
AMEX
SPHY
SPDR Portfolio High Yiel...
LSE
GWP
Gw Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés